STERIS plc

  • TickerSTE
  • ISINIE00BFY8C754
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

Jake Strole

Morningstar | Steris' Narrow Economic Moat Supported By Elevated Investment in Fiscal 2020

We believe management’s investment strategy at Steris has been instrumental in forming a narrow-moat enterprise, deploying capital into internal initiatives and acquisitions to fortify the firm’s position as the global leader in infection prevention. The 1997 purchase of Isomedix formed the foundation upon which the company built its leading position in contract sterilization services in the healthcare industry, capped by the acquisition of U.K.-based Synergy Health in 2015. We think this piece of the business represents the widest-moat segment of the firm, as switching costs and regulatory in...

Jake Strole

Steris' Narrow Economic Moat Supported By Elevated Investment in Fiscal 2020

Narrow-moat Steris finished its fiscal 2019 on a remarkably strong note, posting 9% constant currency organic growth in the quarter and 7.6% for the year. As we update and roll our model, we'll likely raise our $104 per share fair value estimate by a mid-single-digit percentage as some positives are offset by a higher-than-expected capital investment program over the next several years. Strength was broad based across its four businesses, which lays the groundwork for a solid 2020. Our expectati...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

Jake Strole

Morningstar | Steris Posts Strong Finish to Fiscal 2019; Initial 2020 Outlook Ahead of Our Expectations

Narrow-moat Steris finished its fiscal 2019 on a remarkably strong note, posting 9% constant currency organic growth in the quarter and 7.6% for the year. As we update and roll our model, we'll likely raise our $104 per share fair value estimate by a mid-single-digit percentage as some positives are offset by a higher-than-expected capital investment program over the next several years. Strength was broad based across its four businesses, which lays the groundwork for a solid 2020. Our expectations for the coming year fell at the lower end of management's outlook, which calls for 5% to 6% orga...

Jake Strole

Steris Posts Strong Finish to Fiscal 2019; Initial 2020 Outlook Ahead of Our Expectations

Narrow-moat Steris finished its fiscal 2019 on a remarkably strong note, posting 9% constant currency organic growth in the quarter and 7.6% for the year. As we update and roll our model, we'll likely raise our $104 per share fair value estimate by a mid-single-digit percentage as some positives are offset by a higher-than-expected capital investment program over the next several years. Strength was broad based across its four businesses, which lays the groundwork for a solid 2020. Our expectati...

Jake Strole

Morningstar | Steris' Narrow Economic Moat Supported By Elevated Investment in Fiscal 2020

We believe management’s investment strategy at Steris has been instrumental in forming a narrow-moat enterprise, deploying capital into internal initiatives and acquisitions to fortify the firm’s position as the global leader in infection prevention. The 1997 purchase of Isomedix formed the foundation upon which the company built its leading position in contract sterilization services in the healthcare industry, capped by the acquisition of U.K.-based Synergy Health in 2015. We think this piece of the business represents the widest-moat segment of the firm, as switching costs and regulatory in...

Jake Strole

Steris' Narrow Economic Moat Supported By Elevated Investment in Fiscal 2020

Narrow-moat Steris finished its fiscal 2019 on a remarkably strong note, posting 9% constant currency organic growth in the quarter and 7.6% for the year. As we update and roll our model, we'll likely raise our $104 per share fair value estimate by a mid-single-digit percentage as some positives are offset by a higher-than-expected capital investment program over the next several years. Strength was broad based across its four businesses, which lays the groundwork for a solid 2020. Our expectati...

Jake Strole

Morningstar | Steris Posts Strong Finish to Fiscal 2019; Initial 2020 Outlook Ahead of Our Expectations

Narrow-moat Steris finished its fiscal 2019 on a remarkably strong note, posting 9% constant currency organic growth in the quarter and 7.6% for the year. As we update and roll our model, we'll likely raise our $104 per share fair value estimate by a mid-single-digit percentage as some positives are offset by a higher-than-expected capital investment program over the next several years. Strength was broad based across its four businesses, which lays the groundwork for a solid 2020. Our expectations for the coming year fell at the lower end of management's outlook, which calls for 5% to 6% orga...

Jake Strole

Steris Posts Strong Finish to Fiscal 2019; Initial 2020 Outlook Ahead of Our Expectations

Narrow-moat Steris finished its fiscal 2019 on a remarkably strong note, posting 9% constant currency organic growth in the quarter and 7.6% for the year. As we update and roll our model, we'll likely raise our $104 per share fair value estimate by a mid-single-digit percentage as some positives are offset by a higher-than-expected capital investment program over the next several years. Strength was broad based across its four businesses, which lays the groundwork for a solid 2020. Our expectati...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch